Santra 1mg - High-Potency Anastrozole for Estrogen Management
Optimize your hormone management with Santra, a professional-grade aromatase inhibitor. Designed for precision, this formulation is used to effectively manage estrogen levels, helping to prevent the side effects of aromatization such as water retention and gynecomastia. Whether for clinical or fitness-related use, Santra provides a reliable solution for maintaining endocrine balance.
Specifications
| Active Substance | Anastrozole |
| Manufacturer | Sandoz |
| Formulation | 28 pills x 1 mg |
| Classification | Non-steroidal aromatase inhibitor |
| Chemical Formula | C17H19N5 |
| Active Half-Life | 2 days |
Product Overview and Mechanism
Santra is a potent anti-estrogen medication that functions as a highly selective inhibitor of the enzyme aromatase. By inhibiting this enzyme, the drug prevents the conversion of androgens into estrogens, making it an essential tool for controlling estrogen-related side effects.
In the context of bodybuilding and hormone management, Santra is widely utilized to prevent the occurrence of gynecomastia (breast tissue-related) and edema (water retention). Because it is a non-steroidal inhibitor, it offers a targeted approach to estrogen control without the typical side effects associated with steroidal compounds.
The formula is designed for stability and effectiveness. It is important to note that the full physiological effect of the substance is typically observed after 10-14 days of consistent use. As a non-steroidal compound, it does not contribute to hepatotoxicity or significant acne production, making it a versatile option for various user profiles.
Usage and Dosage
For effective management, the recommended dosage is 1mg (1 tablet) per day. It is vital to follow the specific protocols for your individual needs. As with any supplement or pharmaceutical-grade product, consistency is key to achieving the desired results.
FAQ
Is Santra suitable for preventing water retention?
Yes, Santra is highly effective at preventing edema and water retention by managing the aromatization process.
What is the active half-life of this product?
The active half-life of the substance is approximately 2 days.
Does Santra cause acne or liver toxicity?
According to the product profile, Santra is not associated with acne or hepatotoxicity, making it a low-stress option for liver health.
What is the classification of this drug?
Santra is classified as a non-steroidal aromatase inhibitor.